328 related articles for article (PubMed ID: 25071166)
1. CRTC1/MAML2 gain-of-function interactions with MYC create a gene signature predictive of cancers with CREB-MYC involvement.
Amelio AL; Fallahi M; Schaub FX; Zhang M; Lawani MB; Alperstein AS; Southern MR; Young BM; Wu L; Zajac-Kaye M; Kaye FJ; Cleveland JL; Conkright MD
Proc Natl Acad Sci U S A; 2014 Aug; 111(32):E3260-8. PubMed ID: 25071166
[TBL] [Abstract][Full Text] [Related]
2. Aberrantly activated AREG-EGFR signaling is required for the growth and survival of CRTC1-MAML2 fusion-positive mucoepidermoid carcinoma cells.
Chen Z; Chen J; Gu Y; Hu C; Li JL; Lin S; Shen H; Cao C; Gao R; Li J; Ha PK; Kaye FJ; Griffin JD; Wu L
Oncogene; 2014 Jul; 33(29):3869-77. PubMed ID: 23975434
[TBL] [Abstract][Full Text] [Related]
3. Transforming activity of MECT1-MAML2 fusion oncoprotein is mediated by constitutive CREB activation.
Wu L; Liu J; Gao P; Nakamura M; Cao Y; Shen H; Griffin JD
EMBO J; 2005 Jul; 24(13):2391-402. PubMed ID: 15961999
[TBL] [Abstract][Full Text] [Related]
4. CRTC1/MAML2 directs a PGC-1α-IGF-1 circuit that confers vulnerability to PPARγ inhibition.
Musicant AM; Parag-Sharma K; Gong W; Sengupta M; Chatterjee A; Henry EC; Tsai YH; Hayward MC; Sheth S; Betancourt R; Hackman TG; Padilla RJ; Parker JS; Giudice J; Flaveny CA; Hayes DN; Amelio AL
Cell Rep; 2021 Feb; 34(8):108768. PubMed ID: 33626346
[TBL] [Abstract][Full Text] [Related]
5. Gene expression profiling analysis of CRTC1-MAML2 fusion oncogene-induced transcriptional program in human mucoepidermoid carcinoma cells.
Chen J; Li JL; Chen Z; Griffin JD; Wu L
BMC Cancer; 2015 Oct; 15():803. PubMed ID: 26503699
[TBL] [Abstract][Full Text] [Related]
6. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway.
Tonon G; Modi S; Wu L; Kubo A; Coxon AB; Komiya T; O'Neil K; Stover K; El-Naggar A; Griffin JD; Kirsch IR; Kaye FJ
Nat Genet; 2003 Feb; 33(2):208-13. PubMed ID: 12539049
[TBL] [Abstract][Full Text] [Related]
7. CRTC1-MAML2 fusion-induced lncRNA LINC00473 expression maintains the growth and survival of human mucoepidermoid carcinoma cells.
Chen Z; Lin S; Li JL; Ni W; Guo R; Lu J; Kaye FJ; Wu L
Oncogene; 2018 Apr; 37(14):1885-1895. PubMed ID: 29353885
[TBL] [Abstract][Full Text] [Related]
8. t(11;19) translocation and CRTC1-MAML2 fusion oncogene in mucoepidermoid carcinoma.
O'Neill ID
Oral Oncol; 2009 Jan; 45(1):2-9. PubMed ID: 18486532
[TBL] [Abstract][Full Text] [Related]
9. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes.
Coxon A; Rozenblum E; Park YS; Joshi N; Tsurutani J; Dennis PA; Kirsch IR; Kaye FJ
Cancer Res; 2005 Aug; 65(16):7137-44. PubMed ID: 16103063
[TBL] [Abstract][Full Text] [Related]
10. Mucoepidermoid carcinoma of the cervix: another tumor with the t(11;19)-associated CRTC1-MAML2 gene fusion.
Lennerz JK; Perry A; Mills JC; Huettner PC; Pfeifer JD
Am J Surg Pathol; 2009 Jun; 33(6):835-43. PubMed ID: 19092631
[TBL] [Abstract][Full Text] [Related]
11. A closer look at Warthin tumors and the t(11;19).
Fehr A; Röser K; Belge G; Löning T; Bullerdiek J
Cancer Genet Cytogenet; 2008 Jan; 180(2):135-9. PubMed ID: 18206539
[TBL] [Abstract][Full Text] [Related]
12. Role of CRTC1/MAML2 Translocation in the Prognosis and Clinical Outcomes of Mucoepidermoid Carcinoma.
Saade RE; Bell D; Garcia J; Roberts D; Weber R
JAMA Otolaryngol Head Neck Surg; 2016 Mar; 142(3):234-40. PubMed ID: 26796488
[TBL] [Abstract][Full Text] [Related]
13. Primary mucoepidermoid carcinoma of the external auditory canal with a CRTC1::MAML2 fusion: A case report and a review of literature.
De la Sancha C; Kuhar M; Kraft A; Alomari AK
J Cutan Pathol; 2023 Nov; 50(11):947-950. PubMed ID: 37394842
[TBL] [Abstract][Full Text] [Related]
14. The CRTC1-MAML2 fusion is the major oncogenic driver in mucoepidermoid carcinoma.
Chen Z; Ni W; Li JL; Lin S; Zhou X; Sun Y; Li JW; Leon ME; Hurtado MD; Zolotukhin S; Liu C; Lu J; Griffin JD; Kaye FJ; Wu L
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830080
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepidermoid carcinoma.
Nakayama T; Miyabe S; Okabe M; Sakuma H; Ijichi K; Hasegawa Y; Nagatsuka H; Shimozato K; Inagaki H
Mod Pathol; 2009 Dec; 22(12):1575-81. PubMed ID: 19749740
[TBL] [Abstract][Full Text] [Related]
16. Gefitinib Represses JAK-STAT Signaling Activated by CRTC1-MAML2 Fusion in Mucoepidermoid Carcinoma Cells.
Wu Y; He Z; Li S; Tang H; Wang L; Yang S; Dong B; Qin J; Sun Y; Yu H; Zhang Y; Zhang Y; Guo Y; Wang Q
Curr Cancer Drug Targets; 2019; 19(10):796-806. PubMed ID: 30605061
[TBL] [Abstract][Full Text] [Related]
17. Altered Notch signaling resulting from expression of a WAMTP1-MAML2 gene fusion in mucoepidermoid carcinomas and benign Warthin's tumors.
Enlund F; Behboudi A; Andrén Y; Oberg C; Lendahl U; Mark J; Stenman G
Exp Cell Res; 2004 Jan; 292(1):21-8. PubMed ID: 14720503
[TBL] [Abstract][Full Text] [Related]
18. MYC interacts with the human STAGA coactivator complex via multivalent contacts with the GCN5 and TRRAP subunits.
Zhang N; Ichikawa W; Faiola F; Lo SY; Liu X; Martinez E
Biochim Biophys Acta; 2014 May; 1839(5):395-405. PubMed ID: 24705139
[TBL] [Abstract][Full Text] [Related]
19. CRTC1 rearrangements in the absence of t(11;19) in primary cutaneous mucoepidermoid carcinoma.
Lennerz JK; Perry A; Dehner LP; Pfeifer JD; Lind AC
Br J Dermatol; 2009 Oct; 161(4):925-9. PubMed ID: 19438452
[TBL] [Abstract][Full Text] [Related]
20. Translocation t(2;11) in CLL cells results in CXCR4/MAML2 fusion oncogene.
Acunzo M; Romano G; Wernicke D; Balatti V; Rassenti LZ; dell'Aquila M; Kipps TJ; Pekarsky Y; Croce CM
Blood; 2014 Jul; 124(2):259-62. PubMed ID: 24855209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
